
212.70 Delayed Data As of 3:59pm ET | ![]() Today’s Change | 116.08 Today|||52-Week Range 217.51 | +65.51% Year-to-Date |
Why Is Seattle Genetics (SGEN) Down 0.7% Since Last Earnings Report? 11:32am / Zacks.com - Paid Partner Content | Seagen's (SGEN) Combo Drug Expanded-Use sBLA Gets Priority Tag 7:42am / Zacks.com - Paid Partner Content |
Previous close | 213.21 |
Today’s open | 213.21 |
Day’s range | 212.45 - 213.77 |
Volume | 48,519 |
Average volume (3 months) | 1,298,459 |
Market cap | $40.3B |
Earnings growth (last year) | +10.80% |
Earnings growth (this year) | +11.21% |
Earnings growth (next 5 years) | +66.10% |
Revenue growth (last year) | +24.65% |
P/E ratio | NM |
Price/Sales | 12.09 |
Price/Book | 14.27 |
Next reporting date | February 8, 2024 |
EPS forecast (this quarter) | -$0.52 |
Annual revenue (last year) | $2.0B |
Annual profit (last year) | -$610.3M |
Net profit margin | -31.10% |
Sector Health Technology |
Industry Pharmaceuticals: Major |
No executives to display |
Corporate headquarters Bothell, Washington |